{
  "id": 9553403,
  "title": "Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO",
  "url": "https://urgent.news/2026/09/24/quantum-biopharma-licensee-unbuzzd-wellness-to-advance-clinically",
  "topic": "business",
  "section": "Business",
  "published": "2026-09-24T12:04:38.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/quantum-biopharma-licensee-unbuzzd-wellness-to-advance-clinically-validated-alcohol-metabolism-accelerant-after-appointing-zappy-as-ceo"
  },
  "original_language": "en",
  "account": null,
  "summary": "TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma”), today announced its licensee – Unbuzzd Wellness Inc. (the “Company” or “Unbuzzd“), the company behind unbuzzd™ (“unbuzzd”) — the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms, is pleased…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}